United Therapeutics Corporation · NASDAQ:UTHR
Rothblatt Martine A sold 1,500 United Therapeutics Corporation shares (Form 4/A)
Traded May 26, 2026 · Filed Jun 2, 2026
On May 26, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 1,500 United Therapeutics Corporation shares at US$575.96 for US$864K under a trading plan, leaving 43,153 shares. Filed Jun 2, 2026 (Form 4/A).
- Sold
- 1,500 shares
- Price
- US$575.96
- Value
- US$864K
- Holding after
- 43,153 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chairperson & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | Sale | 1,500 | US$575.96 | 43,153 | Direct |
Source
Related
- United Therapeutics Corporation
- Rothblatt Martine A
- United Therapeutics Corporation shareholders
- Form 4 · Rothblatt Martine A · Oct 22, 2026
- Form 4 · Rothblatt Martine A · Oct 21, 2026
- Form 4 · Rothblatt Martine A · Oct 20, 2026
- Form 4 · Rothblatt Martine A · Oct 19, 2026
- Form 4 · Rothblatt Martine A · Oct 16, 2026
- Schedule 13G/A · Rothblatt Martine A · Aug 14, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · Wellington Management Group LLP · Feb 10, 2026